Gordon Reid, president and CEO of Goodreid Investment Counsel
Focus: U.S.equities

MARKET OUTLOOK

The market is reflecting disruption and dislocation more than permanent economic damage. Time will tell if this has staying power. Prevailing trends have accelerated, an example being the e-commerce surge at the expense of brick-and-mortar retail. Money is on the move and your portfolio should be changing as well. Watch valuations off normalized earnings, not those calculated during anomalous times.

TOP PICKS

Gordon Reid's Top Picks

Gordon Reid, president and CEO of Goodreid Investment Counsel discusses his Top Picks: AbbVie, Facebook and FedEx.

ABBVIE (ABBV NYSE)
Latest purchase April 2020 at $82.

AbbVie is making a bold acquisition by purchasing Allergan in a $63 billion deal. The benefits are numerous, from a reduction in product concentration to huge financial growth projections. Layer on the cost synergies and immediately accretive earnings expectations, and at less than 10 times earnings with a dividend yield of 5%, and this proves to be a a very attractive opportunity.

FACEBOOK (FB NASD).
Latest purchase April 2020 at $175

Mobile advertising is the foundation of growth for Facebook. Their social networking offerings are highly coveted, reach billions of consumer and benefit as the hardware and software ecosystems steadily develop. COVID-19 has further entrenched the place of technology-driven social contact.

FEDEX (FDX NYSE)
Latest Purchase April 2020 at $120.

With over $70 billion in sales and operating more than 150 thousand ground vehicles and 650 aircraft, this company is dealing with a changing and challenging economic background. Europe and China have struggled through the trade wars and now coronavirus is having a dramatic impact. This has created an excellent entry point to this stock.

 

DISCLOSURE PERSONAL FAMILY PORTFOLIO/FUND
ABBY Y N Y
FB Y N Y
FDX Y N Y

 

PAST PICKS: APRIL 22,  2019

Gordon Reid's Past Picks

Gordon Reid, president and CEO of Goodreid Investment Counsel discusses his Past Picks: Ciena, CVS Health and Sherwin-Williams.

CIENA CORPORATION (CIEN NYSE)

  • Then: $38.73
  • Now: $48.87
  • Return: 26%
  • Total Return: 26%

CVS HEALTH CORP (CVS NYSE)

  • Then: $52.43
  • Now: $63.50
  • Return: 21%
  • Total Return: 25%

SHERWIN-WILLIAMS (SHW NYSE)

  • Then: $451.89
  • Now: $561.07
  • Return: 24%
  • Total Return: 25%

Total Return Average: 25%

 

       
CIEN Y N Y
CVS Y N Y
SHW Y N Y

 

WEBSITE: www.goodreid.com